Home›Companies›BiVACOR

BiVACOR Inc.

Updated Oct 29, 2026·Latest SEC filing Aug 6, 2024·Suggest an edit

About BiVACOR

BiVACOR is a private company based in Huntington Beach, California. It has reported $24,000,003 raised in two offerings on Form D since February 2023. Its chief executive is James Dillon.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 23, 2024Aug 6, 2024$9,000,003of $28.0M target3$3.0MEquity, OptionsRule 506(b)Form D ↗
Feb 3, 2023Feb 21, 2023$15,000,000of $36.0M target4$3.7MEquity, OptionsRule 506(b)Form D ↗
Total, two offerings$24,000,003

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on BiVACOR's Form D filed Aug 6, 2024.

MM
Matt Mackey
Director
DT
Daniel Timms
Executive officer and director
BC
Bihua Chen
Director
Also a director at BioVentrix and BlossomHill Therapeutics.
RC
Raymond Cohen
Director
Also a director at BioVentrix and JenaValve Technology.
JD
James Dillon
Chief Executive Officer and director
Also an executive officer and director at BioVentrix.
PK
Paul Kelly
Director

Earlier filings also listed William Cohn (director, last listed Feb 2023) and Tom Vassiliades (chief executive officer and director, last listed Feb 2023).

Sources

  1. SECBiVACOR Inc. filing history